Advertisement

The Latest

As spine procedures continue to trend toward the outpatient setting, patients are becoming more empowered to take an active role in managing their well-being and deciding where to have procedures performed, Yesh Navalgund, MD, said.

Spine devicemaker Spineart raised $22.5 million in convertible financing shortly after finishing enrollment for its cervical disc replacement trial.

Advertisement